Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) - Total Liabilities
Based on the latest financial reports, Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) has total liabilities worth CN¥3.52 Billion CNY (≈ $515.48 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Shijiazhuang Yiling Pharmaceutical Co Lt cash conversion from operations to assess how effectively this company generates cash.
Shijiazhuang Yiling Pharmaceutical Co Ltd - Total Liabilities Trend (2008–2024)
This chart illustrates how Shijiazhuang Yiling Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check 002603 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Shijiazhuang Yiling Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Shijiazhuang Yiling Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Group 1 Automotive Inc
NYSE:GPI
|
USA | $-15.30 Million |
|
United Breweries Limited
NSE:UBL
|
India | Rs38.19 Billion |
|
Sensient Technologies Corporation
NYSE:SXT
|
USA | $1.03 Billion |
|
Klabin S.A.
SA:KLBN11
|
Brazil | R$55.91 Billion |
|
Science Applications International Corporation Common Stock
NASDAQ:SAIC
|
USA | $3.85 Billion |
|
Dyno Nobel Ltd
AU:DNL
|
Australia | AU$3.40 Billion |
|
Trex Company Inc
NYSE:TREX
|
USA | $410.00 Million |
|
Shenzhen Fortune Trend Technology Co Ltd
SHG:688318
|
China | CN¥-3.71 Billion |
Liability Composition Analysis (2008–2024)
This chart breaks down Shijiazhuang Yiling Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Shijiazhuang Yiling Pharmaceutical Co Lt.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.85 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.33 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.25 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shijiazhuang Yiling Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shijiazhuang Yiling Pharmaceutical Co Ltd (2008–2024)
The table below shows the annual total liabilities of Shijiazhuang Yiling Pharmaceutical Co Ltd from 2008 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥3.12 Billion ≈ $456.13 Million |
-43.75% |
| 2023-12-31 | CN¥5.54 Billion ≈ $810.87 Million |
+2.51% |
| 2022-12-31 | CN¥5.41 Billion ≈ $791.04 Million |
+41.05% |
| 2021-12-31 | CN¥3.83 Billion ≈ $560.84 Million |
+49.19% |
| 2020-12-31 | CN¥2.57 Billion ≈ $375.92 Million |
+130.02% |
| 2019-12-31 | CN¥1.12 Billion ≈ $163.43 Million |
+12.41% |
| 2018-12-31 | CN¥993.56 Million ≈ $145.39 Million |
+28.11% |
| 2017-12-31 | CN¥775.58 Million ≈ $113.49 Million |
-15.50% |
| 2016-12-31 | CN¥917.83 Million ≈ $134.31 Million |
+4.35% |
| 2015-12-31 | CN¥879.56 Million ≈ $128.71 Million |
+64.77% |
| 2014-12-31 | CN¥533.81 Million ≈ $78.11 Million |
+33.55% |
| 2013-12-31 | CN¥399.69 Million ≈ $58.49 Million |
+24.61% |
| 2012-12-31 | CN¥320.75 Million ≈ $46.94 Million |
-38.76% |
| 2011-12-31 | CN¥523.78 Million ≈ $76.64 Million |
-22.98% |
| 2010-12-31 | CN¥680.08 Million ≈ $99.52 Million |
-5.40% |
| 2009-12-31 | CN¥718.89 Million ≈ $105.20 Million |
+106.65% |
| 2008-12-31 | CN¥347.88 Million ≈ $50.91 Million |
-- |
About Shijiazhuang Yiling Pharmaceutical Co Ltd
Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicine primarily in China. It offers drugs for cardiovascular and cerebrovascular, respiratory, endocrine, neurological, digestive, immune, and urinary diseases, diabetes mellitus, oncology, sleep-improving, and anti-aging. The company also provides dietary supplements, disinfec… Read more